2021 was a phenomenal year for TEDCO (Maryland Technology Development Corporation)! Despite challenges and setbacks due to COVID-19, the venture and equity investment organization pushed boundaries and made phenomenal strides in growth and expansion across the state of Maryland. TEDCO also provided crucial funding, resources, and networking opportunities for entrepreneurs and startups in the state.
Quality assurance is a key function in the biopharma industry that provides a hands-on role in day-to-day operations. It’s a role that allows team members to maintain their fingers on the pulse of the beating heart of a drug manufacturing company. And it’s a role that’s available at one of the biggest drug manufacturing companies in the BioHealth Capital Region.
Secretary of Commerce tours new I-270 Innovation Labs, flexible lab space meeting critical industry need
From left to right: Kelly Shultz – Secretary of Commerce, State of Maryland; Luis Rugeles – Co-founder & CEO, I-270 Innovation Labs; and Doug Bane – Co-founder & COO, I-270 Innovation Labs.
This year, Meridian BioGroup of Frederick, Maryland is celebrating its 15th year in business. The compliance, validation, and regulatory services provider has grown substantially in that time, and continues to put in the work to expand and improve. Co-founders Thomas Blake and Alison Demarest take pride in the work of their employees, Meridian’s work culture, and the expertise of the company in the biotech and pharmaceutical fields.
Intellectual property is the lifeblood of biopharmaceutical companies. Protection of that information is of paramount importance and it is one reason companies seek legal firms that specialize in intellectual property and patent protection.
For many labs with limited funding, equipment failure can put a huge and unwelcome dent in the budget. Is the cost of fixing it more than the cost of replacing it? If it needs to be replaced, can you afford a new piece? What if you’re expanding operations and just need to update your lab with more equipment? More and more, labs are turning to suppliers to purchase used equipment, but that isn’t entirely without its own risks. Here are a few questions to ask if you’re buying used lab equipment.
Since the approval of the first biosimilar drug in the United States six years ago, the market has rapidly expanded and is expected to grow to approximately $23 billion in the U.S. by 2027. And Maryland’s BioFactura anticipates it will be one of the companies at the forefront of this revolution of new medications.
In the pursuit of scientific knowledge, some skills essential to managing projects are overlooked by graduate students and postdoctoral fellows as they pursue academic success. However, these project management skills can be highly prized by future employers, either public or private institutions.
To address this sometimes lacking skillset, Georgetown University Biomedical Graduate Education launched a pilot program to teach these vital tools to postdoctoral fellows. Through the Office of Postdoctoral Development and Training Grant Support, the university launched the Academy for Transferable Management Skills (ATMS) with pilot funding from the Burroughs Wellcome Fund. The ATMS curriculum was put together by experienced industry professionals in order to benefit future generations of biomedical trainees.
Late in 2019, Fulton Bank launched a brand-new division to support emerging Life Science and Technology companies. Many traditional banks have historically shied away from these types of companies, which often operate in pre-revenue business models that are more complicated to assess. However, if successful, these companies represent some of the greatest potential for growth and economic impact.
consortium in 2019. Since that time, the Lab Owl product has been integrated into ARMI’s Tissue Foundry manufacturing process, and the Lab Owl team has made important contributions to several working groups tasked with solving some of the challenges facing tissue engineering and regenerative medicine manufacturing. These working groups include establishing ARMI’s Workforce Characteristics Charter; the Tissue Maturation and Bioreactor Charter; and the Cell Culture and Harvest Charter.